A systemic review of studies on mutations in melanoma by Hocker et al. [45] showed that CDNK2A had statistically higher rates of UVB fingerprint mutations than other genes, such as BRAF and NRAS in melanoma, as well as compared to other non-skin cancers. The gene discussed is NRAS; the disease is melanoma.